This clone is a recombinant human antibody scfv fragment that attaches to EBOV GP. The IgG format binds to Ebola virus glycoprotein with an EC₅₀ of 200 pM or less, as measured by ELISA. The antibody neutralized the three strains named as mayinga, Kikwit 1995 and Makon 2014 at a concentration of 1 μg/mL.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-298 | Recombinant Anti-EBOV GP Antibody | WB, Neut, FuncS | IgG |
PABL-458 | Recombinant Human Anti-EBOV GP Antibody (KZ52 ) | Neut | IgG |
HPAB-0411-FY | Human Anti-EBOV GP Recombinant Antibody (HPAB-0411-FY) | ELISA, FC, FuncS, Neut | Human IgG |
HPAB-0412-FY | Human Anti-EBOV GP Recombinant Antibody (HPAB-0412-FY) | ELISA, FC, FuncS, Neut | Human IgG |
HPAB-0413-FY | Human Anti-EBOV GP Recombinant Antibody (HPAB-0413-FY) | ELISA, FC, Neut | Human IgG |
There are currently no Customer reviews or questions for HPAB-0411-FY-S(P). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.